Are insiders buying DRUG stock?

Yes — 2 distinct insiders have bought DRUG (BRIGHT MINDS BIOSCIENCES INC.) on the open market, including 1 cluster buy where two or more insiders bought within a rolling window. The most recent qualifying activity was Nov 6, 2024.

How much DRUG stock have insiders bought?

Insiders have bought a combined $7.0M of DRUG across 7 open-market purchases, based on SEC Form 4 filings.

What is an insider cluster buy in DRUG?

A cluster buy is two or more distinct BRIGHT MINDS BIOSCIENCES INC. insiders — officers, directors, or 10% owners — each buying DRUG on the open market within a rolling window. DRUG has 1 detected cluster buy to date.

Where does this DRUG insider trading data come from?

Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.

DRUG insider buying

1 cluster buy

BRIGHT MINDS BIOSCIENCES INC. · Healthcare

When two or more insiders at BRIGHT MINDS BIOSCIENCES INC. buy DRUG in a qualifying detection window, the grouped purchases provide a starting point for further research. Below is every cluster we've detected in DRUG plus the full record of qualifying open-market buys, each parsed directly from Form 4 filings and linked back to the source on SEC EDGAR.

Clusters

Distinct insiders

Total bought

$7.0M

Market cap

$652.8M

Detected clusters

Oct 15 – Nov 4, 2024
Detected Nov 4, 2024
2 insiders
Total bought
$7.0M
Market cap
$652.8M

All notable open-market buys in DRUG

Every open-market Form 4 purchase, newest first. Click an insider to see their full buying record across companies.

Date	Insider	Shares	Price	Value	Filing
Nov 4, 2024	Cormorant Asset Management, LPcluster 10% Owner	184,331	$21.70	$4.0M	SEC ↗
Oct 16, 2024	Cormorant Global Healthcare Master Fund, LPcluster 10% Owner	39,743	$23.22	$922.8K	SEC ↗
Oct 16, 2024	Cormorant Global Healthcare Master Fund, LPcluster 10% Owner	7,150	$24.03	$171.8K	SEC ↗
Oct 15, 2024	Cormorant Global Healthcare Master Fund, LPcluster 10% Owner	238,097	$4.53	$1.1M	SEC ↗
Oct 15, 2024	Cormorant Global Healthcare Master Fund, LPcluster 10% Owner	63,173	$5.92	$374.0K	SEC ↗
Oct 15, 2024	Cormorant Global Healthcare Master Fund, LPcluster 10% Owner	19,169	$11.72	$224.7K	SEC ↗
Oct 15, 2024	Cormorant Global Healthcare Master Fund, LPcluster 10% Owner	33,343	$6.42	$214.1K	SEC ↗

More Healthcare stocks with insider cluster buys

All insider buying in Healthcare →

DRUG insider buying — FAQ

Are insiders buying DRUG stock?: Yes — 2 distinct insiders have bought DRUG (BRIGHT MINDS BIOSCIENCES INC.) on the open market, including 1 cluster buy where two or more insiders bought within a rolling window. The most recent qualifying activity was Nov 6, 2024.
How much DRUG stock have insiders bought?: Insiders have bought a combined $7.0M of DRUG across 7 open-market purchases, based on SEC Form 4 filings.
What is an insider cluster buy in DRUG?: A cluster buy is two or more distinct BRIGHT MINDS BIOSCIENCES INC. insiders — officers, directors, or 10% owners — each buying DRUG on the open market within a rolling window. DRUG has 1 detected cluster buy to date.
Where does this DRUG insider trading data come from?: Every figure is parsed directly from SEC Form 4 filings on EDGAR, and each purchase on this page links back to its original filing document.

How we track insider buying in DRUG

We continuously poll SEC EDGAR for new Form 4 filings and parse every open-market purchase (transaction code P). A cluster is recorded when two or more distinct insiders — officers, directors, or 10% owners — each buy DRUG within a rolling window. We track clusters at every company size, from micro-caps to mega-caps. Transactions link to official filings; prices and market capitalizations may be cached market data. Read our methodology and data limits before interpreting the figures. What counts as a cluster buy?

This page is informational and reflects public filing data. It is not investment advice or a recommendation regarding DRUG.